Ke Chen

9.9k total citations · 2 hit papers
213 papers, 6.6k citations indexed

About

Ke Chen is a scholar working on Molecular Biology, Cancer Research and Epidemiology. According to data from OpenAlex, Ke Chen has authored 213 papers receiving a total of 6.6k indexed citations (citations by other indexed papers that have themselves been cited), including 118 papers in Molecular Biology, 54 papers in Cancer Research and 30 papers in Epidemiology. Recurrent topics in Ke Chen's work include Cancer-related molecular mechanisms research (35 papers), RNA modifications and cancer (25 papers) and Circular RNAs in diseases (20 papers). Ke Chen is often cited by papers focused on Cancer-related molecular mechanisms research (35 papers), RNA modifications and cancer (25 papers) and Circular RNAs in diseases (20 papers). Ke Chen collaborates with scholars based in China, United States and Canada. Ke Chen's co-authors include Xiuli An, Narla Mohandas, Joel Anne Chasis, Hua Xu, Zhangqun Ye, Susanne Heck, Jing Liu, Chunjiang He, Haibing Xiao and Hongliang Li and has published in prestigious journals such as Proceedings of the National Academy of Sciences, Nucleic Acids Research and Journal of Biological Chemistry.

In The Last Decade

Ke Chen

201 papers receiving 6.6k citations

Hit Papers

align trajectories

What are hit papers?

Hit papers significantly outperform the citation benchmark for their cohort. A paper qualifies if it has ≥500 total citations, achieves ≥1.5× the top-1% citation threshold for papers in the same subfield and year (this is the minimum needed to enter the top 1%, not the average within it), or reaches the top citation threshold in at least one of its specific research topics.

CircRNA inhibits DNA damage repair by interacting with host gene

2020 280 citations Xiaolong Xu, Jingwei Zhang et al. Molecular Cancer profile →
Systemic immune-inflammatory biomarkers (SII, NLR, PLR and LMR) linked to non-alcoholic fatty liver disease risk

2024 51 citations Ke Chen et al. profile →

Peers — A (Enhanced Table)

Peers by citation overlap · career bar shows stage (early→late) cites · hero ref

Name	h						Papers	Cites
Ke Chen China	44	4.1k	2.1k	867	631	616	213	6.6k
Ming Zhan China	47	5.2k 1.3×	2.1k 1.0×	667 0.8×	636 1.0×	632 1.0×	167	7.7k
Jinliang Xing China	46	4.0k 1.0×	2.3k 1.1×	782 0.9×	636 1.0×	631 1.0×	160	6.3k
Junping Zhang China	45	3.0k 0.7×	1.2k 0.6×	845 1.0×	679 1.1×	327 0.5×	229	5.5k
Changqian Wang China	34	3.0k 0.7×	2.0k 1.0×	477 0.6×	621 1.0×	317 0.5×	123	5.4k
Ming Liu China	43	3.4k 0.8×	1.4k 0.7×	672 0.8×	829 1.3×	307 0.5×	307	6.9k
Fuquan Yang China	43	4.7k 1.1×	1.4k 0.7×	584 0.7×	847 1.3×	607 1.0×	173	7.9k
Dong Wang China	49	6.8k 1.7×	3.6k 1.7×	642 0.7×	693 1.1×	299 0.5×	248	9.4k
Fei Wang China	41	3.5k 0.8×	2.4k 1.1×	1.1k 1.3×	513 0.8×	324 0.5×	313	6.6k
Nicolas Fernandez United States	11	5.0k 1.2×	1.4k 0.6×	515 0.6×	1.2k 1.9×	640 1.0×	29	8.2k
Bo Wang China	43	4.7k 1.1×	3.2k 1.5×	1.1k 1.2×	666 1.1×	794 1.3×	169	7.9k

Countries citing papers authored by Ke Chen

Since Specialization

Citations

This map shows the geographic impact of Ke Chen's research. It shows the number of citations coming from papers published by authors working in each country. You can also color the map by specialization and compare the number of citations received by Ke Chen with the expected number of citations based on a country's size and research output (numbers larger than one mean the country cites Ke Chen more than expected).

Fields of papers citing papers by Ke Chen

Since Specialization

Physical SciencesHealth SciencesLife SciencesSocial Sciences

This network shows the impact of papers produced by Ke Chen. Nodes represent research fields, and links connect fields that are likely to share authors. Colored nodes show fields that tend to cite the papers produced by Ke Chen. The network helps show where Ke Chen may publish in the future.

Co-authorship network of co-authors of Ke Chen

This figure shows the co-authorship network connecting the top 25 collaborators of Ke Chen. A scholar is included among the top collaborators of Ke Chen based on the total number of citations received by their joint publications. Widths of edges represent the number of papers authors have co-authored together. Node borders signify the number of papers an author published with Ke Chen. Ke Chen is excluded from the visualization to improve readability, since they are connected to all nodes in the network.

All Works

Sort: Min cites: Since: Top N: Style:

20 of 20 papers shown

Xie, Guijuan, et al.. (2025). Metabolic regulation and quality enhancement mechanisms in dendrobium officinale flower tea aroma-crafting processes revealed by fuzzy mathematics and metabolomics. Food Chemistry X. 29. 102785–102785.

Sun, Dan‐Qin, Jiahui Zhang, Hong Tang, et al.. (2025). Oxidized-LDL aggravates renal injury via tubular cuproptosis. Cellular Signalling. 132. 111839–111839. 2 indexed citations

Lei, Yao, Xinyang Zhang, Xiaoqing Li, et al.. (2025). circAFF2 promotes the development of AML by binding to PML mRNA. Oncogene. 44(18). 1234–1244. 1 indexed citations

Zeng, Yingying, Chong Lu, Hui Cai, et al.. (2024). Edaravone alleviated allergic airway inflammation by inhibiting oxidative stress and endoplasmic reticulum stress. European Journal of Pharmacology. 966. 176317–176317. 5 indexed citations

Chen, Ke, Liu He, Xianqing Wang, et al.. (2024). Data‐driven classification of left atrial morphology and its predictive impact on atrial fibrillation catheter ablation. Journal of Cardiovascular Electrophysiology. 35(4). 811–820. 3 indexed citations

Chen, Nannan, et al.. (2024). Forkhead box O-1 regulates the biological behavior of BMP-2-induced human bone mesenchymal stem cells through mitochondrial dynamics and autophagy. SHILAP Revista de lepidopterología. 25(4). 869–882. 1 indexed citations

Chen, Yu, Hui Cai, Yingying Zeng, et al.. (2024). Lentinan attenuates allergic airway inflammation and epithelial barrier dysfunction in asthma via inhibition of the PI3K/AKT/NF-κB pathway. Phytomedicine. 134. 155965–155965. 10 indexed citations

Li, Rongxin, et al.. (2023). Neddylation of EphB1 Regulates Its Activity and Associates with Liver Fibrosis. International Journal of Molecular Sciences. 24(4). 3415–3415. 11 indexed citations

Dong, Xin, Ke Chen, Wenbo Chen, et al.. (2022). circRIP: an accurate tool for identifying circRNA–RBP interactions. Briefings in Bioinformatics. 23(4). 21 indexed citations

10.

Hu, Zhiquan, et al.. (2022). Identification of Long Non-Coding RNA MIR4435-2HG as a Prognostic Biomarker in Bladder Cancer. Genes. 13(8). 1462–1462. 4 indexed citations

11.

Chen, Ke, et al.. (2021). Clinical features and risk factors of postoperative in-hospital mortality following surgical repair of Stanford type A acute aortic dissection. BMC Cardiovascular Disorders. 21(1). 392–392. 10 indexed citations

12.

Li, Jiong, Ke Chen, Xin Dong, et al.. (2021). YTHDF1 promotes mRNA degradation via YTHDF1‐AGO2 interaction and phase separation. Cell Proliferation. 55(1). e13157–e13157. 70 indexed citations

13.

Xu, Xiaolong, Jingwei Zhang, Yihao Tian, et al.. (2020). CircRNA inhibits DNA damage repair by interacting with host gene. Molecular Cancer. 19(1). 128–128. 280 indexed citations breakdown →

14.

Chen, Ke, et al.. (2020). Observation of the effect of postural modified Valsalva manoeuvre in terminating paroxysmal supraventricular tachycardia. Zhongguo jiceng yiyao. 27(3). 306–308. 2 indexed citations

15.

Song, Zhengshuai, Qi Cao, Hailong Ruan, et al.. (2018). RCAN1.4 acts as a suppressor of cancer progression and sunitinib resistance in clear cell renal cell carcinoma. Experimental Cell Research. 372(2). 118–128. 18 indexed citations

16.

Chen, Ke, Haibing Xiao, Jin Zeng, et al.. (2016). Alternative Splicing of EZH2 pre-mRNA by SF3B3 Contributes to the Tumorigenic Potential of Renal Cancer. Clinical Cancer Research. 23(13). 3428–3441. 81 indexed citations

17.

Chen, Yong, Zhenzhen Zhang, Na‐Na Tao, et al.. (2016). SIRT6 Overexpression Potentiates Apoptosis Evasion in Hepatocellular Carcinoma via BCL2-Associated X Protein–Dependent Apoptotic Pathway. Clinical Cancer Research. 22(13). 3372–3382. 78 indexed citations

18.

Gan, Yu, Weimin Yao, Kiranmai Gumireddy, et al.. (2014). Pseudogene PTENP1 Functions as a Competing Endogenous RNA to Suppress Clear-Cell Renal Cell Carcinoma Progression. Molecular Cancer Therapeutics. 13(12). 3086–3097. 166 indexed citations

19.

Wu, Kongming, Zhaoming Li, Shaoxin Cai, et al.. (2013). EYA1 Phosphatase Function Is Essential to Drive Breast Cancer Cell Proliferation through Cyclin D1. Cancer Research. 73(14). 4488–4499. 71 indexed citations

20.

Chen, Ke, et al.. (2009). Television and DVD/VCD exposure in children younger than three years old in Wenzhou city. 10(12). 1060–1064. 1 indexed citations

Rankless uses publication and citation data sourced from OpenAlex, an open and comprehensive bibliographic database. While OpenAlex provides broad and valuable coverage of the global research landscape, it—like all bibliographic datasets—has inherent limitations. These include incomplete records, variations in author disambiguation, differences in journal indexing, and delays in data updates. As a result, some metrics and network relationships displayed in Rankless may not fully capture the entirety of a scholar's output or impact.

Explore authors with similar magnitude of impact